Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Fate Therapeutics, Inc. Financials Banner

Fate Therapeutics, Inc. Financials

FATE Stock Analysis

Page title

Section title

FATE Income Statement Key Metrics

  • Revenue(TTM)12.32 M
  • Gross Profit(TTM)-6.85 M
  • EBITDA(TTM)-181.08 M
  • Net Income(TTM)-175.72 M
  • EPS Diluted(TTM)-1.71

Decode FATE's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

FATE earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of FATE (0.712) is higher than the average of its peers (0.202).

Net Profit Margin vs Peers

Net profit margin ratio of FATE (-2.533) is higher than the average of its peers (-9.597).

FATE Return on Equity

See how efficiently FATE generates profit for it's shareholders.

-43.68%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of FATE (-0.437) is higher than the average of its peers (-0.828).

Return on Equity Growth

FATE's Return on Equity has shown poor growth over the past 10 years, increasing by only -7.11%.

FATE Revenue Growth

See how FATE has grown it's revenue over the past 10 years.


Revenue Growth

FATE's revenue has grown significantly over the past 10 years, increasing by over 0%.

FATE FY, 2023 Revenue Breakdown

See how FATE converts it's revenue into profit.

FATE Balance Sheet Health

FATE Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

FATE financial position analysis

Short Term Liabilities

FATE's short term assets($332M) can safely cover it's short term liabilities($39M).

Long Term Liabilities

FATE's short term assets($332M) can safely cover it's long term liabilities($99M).

FATE Debt to Equity